AMAG earnings call for the period ending September 30, 2019.
News & Analysis: AMAG Pharmaceuticals
The drugmaker's Q3 results didn't matter very much in light of the prospect that it might have to yank Makena from the market.
Shares tumble after an FDA advisory committee recommends pulling one of the company's key drugs from the market. Here are the must-know details.
It continues to enjoy a strong rebound after a sell-off last week that investors seem to think was overdone.
AMAG earnings call for the period ending June 30, 2019.
The drugmaker exited a key market, causing its top and bottom lines to tank in the second quarter.
A high-profile analyst questioned the company's recent FDA approval.
Two hope to pick up additional indications for existing blockbuster drugs, while another could score a big victory for a new drug.
AMAG earnings call for the period ending March 31, 2019.
AMAG earnings call for the period ending December 31, 2018.